Summary In this study, the role of parity in conferring protection of the mammary gland against chemical carcinogenesis induced by 7,12-dimethylbenz(a)anthracene (DMBA) was investigated. Experiments were also carried out to determine if an 'interrupted' pregnancy was capable of reducing the incidence of mammary tumour induction. Since it has been suggested that morphological development or the proliferative pattern of the mammary gland at the time of carcinogen administration may be involved in reducing the susceptibility of the mammary gland to chemical carcinogenesis, experiments were designed to elucidate the possible influence of these two factors. Sprague-Dawley female rats were mated and were either allowed to complete pregnancy and parturition or were subjected to Caesarian section on day 5, 10 or 15 of the pregnancy. When DMBA was administered i.v. to animals which had been allowed to complete a full-term pregnancy, only 14% developed tumours, compared to 70% in age-matched nulliparous controls. Termination of the pregnancy on days 5, 10 or 15 was as effective in reducing tumour incidence as full-term gestation and parturition, but still resulted in partial and statistically significant inhibition, compared to age-matched nulliparous controls. There was no significant difference in 3H-thymidine labelling index (LI) at the time of DMBA treatment in the parous rats compared to age-matched nulliparous controls. We also observed no significant differences in the morphological development of the mammary gland in parous and nulliparous rats of the same age. These results indicate that the protective mechanism may not lie in the mammary gland per se, but may indeed be a host factor, such as hormonal or immunological changes occurring in the host as a result of the pregnancy.
Epidemiologic observations have indicated that early fullterm pregnancy renders breast tissue less susceptible to the action of a carcinogen (MacMahon et al., 1973; Valaoras et al., 1969) and late pregnancy and nulliparity have been shown to be associated with a higher risk of breast cancer (MacMahon et al., 1973; Wynder et al., 1960; Cutler, 1962) . However, the mechanism by which parity confers refractoriness of the mammary gland to carcinogenesis is not clearly understood, although the epidemiologic studies demonstrating this effect have been mimicked, using experimental animals (Dao & Pazik, 1981; Russo & Russo, 1980) . It has been shown that while nulliparous rats are susceptible to mammary carcinogenesis by 7,12-dimethylbenz[a]-anthracene (DMBA), parous rats of the same age are protected against the effect of the carcinogen. However, the relative importance of two factors, i.e., the age at which first pregnancy occurs and whether or not a full-term pregnancy is required to achieve the most effective degree of inhibition, remains unclear. Earlier reports from our laboratory have demonstrated that early full-term pregnancy in rats induced total protection of the mammary gland against carcinogenesis. The purpose of the present study was to further extend our investigation to elucidate the possible mechanism by which pregnancy inhibits mammary carcinogenesis, and to determine if a full-term pregnancy was required to induce refractoriness of the mammary gland.
Materials and methods
Female and male Sprague-Dawley rats were obtained from Harlan Sprague-Dawley (Madison, WI) for this study. The animals were maintained in a temperature-controlled (24+ 1°C) room with a daily cycle of 14h light and 10h darkness. Females between the ages of 40-50 days were allowed to mate with 90-day-old male rats, three females being housed with one male. Mating started when the females were 40 days old and no rats over the age of 49 days were used for mating in these experiments. Vaginal smears were taken daily to determine when conception had occurred. The presence of a mucous plug or of sperm in the smear was taken as an indication of the exact day of conception. Pregnancy was subsequently confirmed by either parturition or uterine examination at the time of Caesarean -section.
When pregnancy was established, the pregnant rats were placed in individual cages and divided into 5 groups. The rats in group no. 1 were allowed to complete gestation and parturition. The pups were removed at birth and the rats were allowed to rest for 15 days in order for involution of the mammary gland to occur. The animals in group no. 2 were treated similarly to those in group no. 1, except that they were allowed to lactate for five days following delivery. At the end of 5 days, the pups were removed and fifteen days were allowed for involution of the mammary gland to take place. In group no. 3, pregnancy was terminated by Caesarean section on the 5th day of pregnancy. In groups no. 4 and no. 5, pregnancy was terminated in the same manner on day 10 and day 15 of pregnancy, respectively. The animals in the three groups undergoing Caesarean section were also allowed 15 days following termination of the pregnancy, in order for involution of the mammary gland to occur. At the end of the 15-day resting period, all rats were given an i.v. injection of fat emulsion containing DMBA (3mg-1 lOOg body wt). Controls were age-matched nulliparous females treated in the same manner as the parous rats. The animals were weighed and palpated weekly for tumours. At 120 days after treatment with DMBA, all animals were killed and autopsied, to determine if nonpalpable tumours were present. Tumours were excised and placed in Bouin's fixative for histological examination.
At the time of DMBA treatment, ten rats in each group, including the nulliparous controls, were sacrificed and the mammary glands fixed in alcohol-formalin-chloroform fixative (Sinha & Pazik, 1981) Two groups of rats were allowed to complete a full-term pregnancy, but in one group, the rats were allowed to lactate for 5 days following delivery. The pups were then removed and the rats allowed to rest for 15 days prior to administration of DMBA. We observed no significant differences in tumorigenesis between the lactating or nonlactating groups. Of the rats which became pregnant between the ages of 40-46 days and were allowed to lactate for 5 days after parturition, 5/30 (16.6%) developed tumours. These rats were given DMBA at the age of 81 days. When similar rats without lactation were given DMBA, 5/37 (13.5%) developed tumours. Difference between these two groups were not statistically significant. Both groups were significantly different from the agematched nulliparous controls, which demonstrated a 70% rate of tumour induction.
In group 3, pregnancy was terminated on the fifth day of pregnancy and the carcinogen was administered 15 days later. In this group, 13/27 (48%) developed tumours. When pregnancy was terminated on either day 10 or day 15, followed by carcinogen administration 15 days later, tumorigenesis was 12/24 (50%) and 14/31 (45%), respectively, whereas the age-matched nulliparous controls had a tumour incidence of 88% and 86%, respectively. This difference was also statistically significant (Table I, Figure  1 ). These data indicate that full-term pregnancy results in the greatest degree of tumour inhibition, since the incidence of mammary tumorigenesis was reduced from 70% in the controls to 14% in the full-term group. However, interrupted pregnancy also appeared to confer some degree of protection, since it resulted in a tumour incidence of 50% and 45%, as compared to 88% and 86% in nulliparous agematched controls. There did not appear to be any discernible difference if the pregnancy was terminated at day 5, 10 or 15.
Average tumours per tumour bearing rats in nulliparous controls were 2.9 while in parous and parous lactating rats were 2.6 and 2.0 respectively. In the 5, 10 and 15 days Csection groups the average tumours/tumour bearing rats were 2.5, 2.0 and 2.6. The difference in number of tumour between groups was not statistically significant. (± 1.20) end buds and 32.00 (± 2.10) alveolar buds per mm2.
3H-thymidine labelling index
The differences between the parous and nulliparous glands were not statistically significant. Figure 7 Enlarged area of an alveolar area from virgin control rat. H&E (x25). (Cutler, 1962; Russo & Russo, 1980 (Russo & Russo, 1980; Marchant, 1955; 1959) . It should be noted that Russo and Russo (1980) observed the presence of more benign tumours in the groups of rats allowed to lactate. Marchant (1955, 1959) The mechanism by which pregnancy protects the mammary gland against carcinogenesis is not clearly understood. Russo and Russo (1980) suggested that morphological differentiation of the mammary gland confers protection against carcinogenesis. These authors hypothesized that during pregnancy terminal end buds and ductal buds become differentiated into alveolar buds which are known to be less susceptible to carcinogenesis. This suggestion, however, was not supported by our present findings, since we failed to observe any significant differences in morphological differentiation between the parous rats and their age-matched nulliparous counterparts. When wholemount preparations from these two groups of animals were compared, both showed the presence of mostly alveolar growth, and in both groups, there were very limited areas showing few terminal end buds. It would seem that predominately alveolar structure may be a characteristic of age, rather than a consequence of pregnancy. It should be noted that despite the similarities in morphology, the tumour incidence in the nulliparous rats was significantly higher than that in the age-matched parous animals.
The level of DNA synthesis at the time of carcinogen treatment has been shown to be an important factor influencing carcinogenesis (Lin et al., 1976; Nagasawa & Vorherr, 1977) . In the mitotically static mammary glands of older rats, tumour incidence was low, whereas in vounger rats having higher levels of DNA synthesis in the mammary gland, the tumour incidence was significantly higher (Sinha et al., 1983) . Acceleration of DNA synthesis in the mammary gland of older rats could overcome the refractory effect of age, resulting in higher levels of tumour incidence (Sinha & Dao, 1980) . However, in the present study, the level of DNA synthesis in the mammary gland of the parous rats at the time of carcinogen treatment did not show a statistically significant difference compared to that in nulliparous animals, although there was a significant difference in tumour incidence between the two groups. This was true for both the full-term and incomplete pregnancy groups, when compared to age-matched nulliparous controls. It appears that neither morphological changes nor levels of DNA synthesis in the mammary gland, as a result of pregnancy, exert an inhibitory effect on mammary carcinogenesis. Vonderhaar and Topper (1974) Sinha and Dao (1980) . Since (Simmons & Russell, 1966; Heyner, 1973; Patthey & Edidin, 1973) ; in placental cells (Sellens et al., 1978; Wegmann et al., 1979) ; and in trophoblasts (Loke et al., 1971) . One category of antigens, designated as 'oncofetal antigens', such as alpha foetoprotein, chorionic gonadotropin, and chorionic somatomammotropin, also result in stimulus to the mother. In addition, recent investigations have revealed that several other antigens are produced by both the foetus and/or placenta and also by breast tumours. These would include pregnancy associated alpha-2 glycoprotein (Sarcione et al., 1983) ; pregnancyspecific beta-I glycoprotein (Grudzinskas et al., 1980) ; placental lactogen (Monteiro et al., 1982) ; and placental protein 5 (Bremner et al., 1981) .
Thus, it appears reasonable to suggest that both foetoplacental tissue and mammary tumours may produce some antigens in common, against which the mother has been immunized as a result of the pregnancy. This immunity may well be maintained in the mother after the pregnancy has been completed. It is our hypothesis that antibodies against some specific substances produced by breast tumours, being present in the parous female rat, are capable of recognizing the newly transformed mammary cells and act against those cells, thus providing an immunosurveillance mechanism which would 'protect' the parous female rat against subsequent tumour development. Our laboratory is now investigating the possible mechanisms by which this might occur.
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